When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IDRA - Idera Pharmaceuticals: Enter Now Before Phase III Melanoma Trial Data Is Released
Idera Pharmaceuticals Inc.
As was reported last year in phase II results, tilsotolimod is effective in combination with Yervoy to treat refractory advanced melanoma.
Idera's current capitalization, around $98 million, offers limited downside risk and huge upside potential.
Idera offers a good entry opportunity as a speculative investment at current levels, pending the next Illuminate-301 results for the first quarter of 2021.